Streetbeat News

Revenues

CAT

Caterpillar's executive has stated that the company is witnessing continued growth in non-residential construction in North America. However, the CEO also noted a reduction in dealer orders for construction products, which was anticipated.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:44 pm

TFIN

UPS

Coyote Logistics, a UPS company, has joined the TriumphPay payments network. This partnership will allow Coyote to offer its carriers a seamless and integrated payment experience.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:44 pm

EVOK

Evoke Pharma (NASDAQ:EVOK) and EVERSANA have presented real-world data demonstrating that GIMOTI, a nasal spray for treating diabetic gastroparesis (DGP), reduces healthcare costs compared to oral metoclopramide. The data, presented at the American College of Gastroenterology 2023 Annual Meeting, shows that DGP patients treated with GIMOTI were less likely to visit the emergency department or be admitted to the hospital. Over a six-month period, GIMOTI patients spent approximately $15,000 less than those on oral metoclopramide.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:42 pm

SPY

The Employment Cost Index for Q3 has come in at 1.1%, slightly above the estimated 1%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:30 pm

AAPL

HNHPF

Foxconn Technology Group is expected to have a strong October due to orders for Apple's M3-powered new MacBook Pro and iMac. Foxconn is also responsible for components such as chassis.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:15 pm

NUWE

SeaStar Medical, a strategic partner of Nuwellis, Inc. (NASDAQ:NUWE), has received an Approvable Letter from the FDA for its pediatric Selective Cytopheretic Device (SCD-PED). The device provides a new therapy option for children with acute kidney injury and sepsis. Nuwellis and SeaStar Medical have an exclusive U.S. license and distribution agreement for Nuwellis to distribute the SCD-PED. The approval of this device will represent a new revenue stream for Nuwellis.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:10 pm

CVLT

Commvault has increased its FY24 revenue outlook to $812M-$822M, up from the previous $805M-$815M, with a consensus of $813.73M. The company expects a 14% YoY growth in total ARR, subscription revenue between $408M and $418M, a 50 to 100 basis points YoY growth in non-GAAP operating margin, and a free cash flow of approximately $170M.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:50 am

CVLT

Commvault has provided guidance for Q3 of fiscal year 2024, expecting total revenues to be between $206M and $210M, which is above the consensus of $205.43M. The company also expects subscription revenue to be between $106M and $110M, and a non-GAAP operating margin of approximately 21%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:49 am

RGEN

Repligen Corporation has revised its FY23 revenue guidance to $635M-$645M, down from the previous range of $635M-$665M. The new guidance is slightly below the consensus estimate of $644.53M.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:38 am

VNCE

Vince Holding has announced a transformation program that is expected to generate over $30 million in savings over the next three years.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:38 am